Munich - Delayed Quote EUR

SELLAS Life Sciences Group Inc (RXK3.MU)

1.4940
-0.0410
(-2.67%)
At close: May 30 at 5:25:50 PM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
1,000
7,600
Cost of Revenue
100
--
0
100
200
Gross Profit
900
--
0
900
7,400
Operating Expense
27,931
31,513
37,869
32,850
26,994
Operating Income
-27,931
-31,513
-37,869
-31,950
-19,594
Net Non Operating Interest Income Expense
803
632
525
317
6
Other Income Expense
4,949
--
4
-9,668
-1,348
Pretax Income
-27,128
-30,881
-37,340
-41,301
-20,936
Tax Provision
--
--
--
0
-237
Net Income Common Stockholders
-27,128
-30,881
-37,340
-41,301
-20,699
Diluted NI Available to Com Stockholders
-27,128
-30,881
-37,340
-41,301
-20,699
Basic EPS
-0.36
-0.50
-1.34
-2.13
-1.34
Diluted EPS
-0.36
-0.50
-1.34
-2.13
-1.34
Basic Average Shares
71,939.2430
61,202.4120
27,777.1110
19,395.7090
15,481.1130
Diluted Average Shares
71,939.2430
61,202.4120
27,777.1110
19,395.7090
15,481.1130
Total Operating Income as Reported
-27,931
-31,513
-37,869
-41,950
-25,294
Total Expenses
27,931
31,513
37,869
32,950
27,194
Net Income from Continuing & Discontinued Operation
-27,128
-30,881
-37,340
-41,301
-20,699
Normalized Income
-27,128
-30,881
-37,344
-31,633
-19,366.2596
Interest Income
803
632
525
317
6
Net Interest Income
803
632
525
317
6
EBIT
-27,931
-31,513
-37,869
-31,950
-19,594
EBITDA
-27,931
-31,513
-37,869
-31,950
-19,594
Reconciled Cost of Revenue
100
--
0
100
200
Net Income from Continuing Operation Net Minority Interest
-27,128
-30,881
-37,340
-41,301
-20,699
Total Unusual Items Excluding Goodwill
4,949
--
4
-9,668
-1,348
Total Unusual Items
4,949
--
4
-9,668
-1,348
Normalized EBITDA
-27,931
-31,513
-37,873
-22,282
-18,246
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
-15.2596
12/31/2021 - 12/14/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

GXE.F Galapagos NV
25.16
-1.02%
 
9WV.BE Nutriband Inc
5.60
+2.75%
 
25I.SG ImmuPharma PLC
0.0210
-20.75%
 
600161.SS TIANTAN BIO
19.13
-0.52%
 
8EM.BE Editas Medicine Inc
1.5635
-4.75%
 
BCX.WA Bioceltix S.A.
103.80
-4.07%
 
ATOS.MX Atossa Therapeutics, Inc.
16.00
0.00%
 
0M4.F Mersana Therapeutics, Inc.
0.2546
-1.36%
 
22Z.SG Zealand Pharma A/S
60.78
+0.10%
 
GYX.F Futura Medical plc
0.0870
+2.35%